arrow
I

Imtiaz A. Samjoo

eversanatm
H指数:18
被引数:1,393

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A Systematic Literature Review of the Effectiveness of CDK 4/6 Inhibitors for First-Line Treatment of HR+/HER2− Advanced/Metastatic Breast Cancer: A Comparison of Real-World Evidence

CDK 4/6抑制剂在HR+/HER2−晚期/转移性乳腺癌一线治疗中的有效性:真实世界证据的系统文献综述

Cancers
IF4.4
2026-07-230
OA
Real-world effectiveness and safety of CDK4/6i in elderly and BIPOC patients with HR+/HER2- advanced/metastatic breast cancer: an updated systematic literature review

CDK4/6i在老年和BIPOC患者中HR+/HER2-晚期/转移性乳腺癌的真实世界有效性与安全性:一项更新的系统文献综述

2025-08-150
OA
Indirect Treatment Comparisons in Healthcare Decision Making: A Targeted Review of Regulatory Approval, Reimbursement, and Pricing Recommendations Globally for Oncology Drugs in 2021-2023 (nov,10.1007/s12325-024-03013-6,2024)
2025-01-060
OAAI
Indirect Treatment Comparisons in Healthcare Decision Making: A Targeted Review of Regulatory Approval, Reimbursement, and Pricing Recommendations Globally for Oncology Drugs in 2021-2023

医疗保健决策中的间接治疗比较: 2021-2023全球肿瘤药物监管批准,报销和定价建议的有针对性的审查

2024-11-122
OAAI